Cargando…
Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
In metastatic renal cell carcinoma, complete response to first-line antiangiogenic agents is rare and resistance to therapy often develops. Protocols for sequential treatment with angiogenesis and mTOR inhibitors are under evaluation to improve outcomes. In this observational, real-world study, pati...
Autores principales: | Rossetti, Sabrina, D'Aniello, Carmine, Iovane, Gelsomina, Scagliarini, Sarah, Laterza, Maria M., De Vita, Fernando, Savastano, Clementina, Cartenì, Giacomo, Porricelli, Maria A., Berretta, Massimiliano, Pisconti, Salvatore, Facchini, Gaetano, Cavaliere, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517440/ https://www.ncbi.nlm.nih.gov/pubmed/28775690 http://dx.doi.org/10.3389/fphar.2017.00484 |
Ejemplares similares
-
Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016) -
Corrigendum: Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016) -
Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
por: D'Aniello, Carmine, et al.
Publicado: (2019) -
Exploring the molecular aspects associated with testicular germ cell tumors: a review
por: Facchini, Gaetano, et al.
Publicado: (2017) -
Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival
por: Facchini, Gaetano, et al.
Publicado: (2016)